ClinicalTrials.gov
ClinicalTrials.gov Menu

Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02701400
Recruitment Status : Recruiting
First Posted : March 8, 2016
Last Update Posted : January 2, 2018
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Taofeek K. Owonikoko, Emory University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2019
  Estimated Study Completion Date : August 2020